🇺🇸 FDA
Pipeline program

Bexarotene 1% gel

00-031

Phase 2 small_molecule terminated

Quick answer

Bexarotene 1% gel for Parapsoriasis is a Phase 2 program (small_molecule) at LIGAND PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
LIGAND PHARMACEUTICALS INC
Indication
Parapsoriasis
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials